280 related articles for article (PubMed ID: 17043436)
41. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
[TBL] [Abstract][Full Text] [Related]
42. Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis.
Du Pan SM; Dehler S; Ciurea A; Ziswiler HR; Gabay C; Finckh A;
Arthritis Rheum; 2009 May; 61(5):560-8. PubMed ID: 19405000
[TBL] [Abstract][Full Text] [Related]
43. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
[TBL] [Abstract][Full Text] [Related]
44. Etanercept-induced subacute cutaneous lupus erythematosus.
Bleumink GS; ter Borg EJ; Ramselaar CG; Stricker BH
Rheumatology (Oxford); 2001 Nov; 40(11):1317-9. PubMed ID: 11709621
[No Abstract] [Full Text] [Related]
45. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
Broshtilova V; Iliev E; Gantcheva M
Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
[TBL] [Abstract][Full Text] [Related]
46. Leukocytoclastic vasculitis due to etanercept.
Galaria NA; Werth VP; Schumacher HR
J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
[TBL] [Abstract][Full Text] [Related]
47. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
48. Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy.
Smith KJ; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):953-6. PubMed ID: 11712048
[TBL] [Abstract][Full Text] [Related]
49. [Efficacy and adverse events of etanercept in patients with rheumatoid arthritis: reports of postmarketing surveillance in Japan].
Eguchi K
Nihon Rinsho; 2007 Jul; 65(7):1259-66. PubMed ID: 17642241
[TBL] [Abstract][Full Text] [Related]
50. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.
Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O
J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583
[TBL] [Abstract][Full Text] [Related]
51. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
Segal B; Rhodus NL; Patel K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
[TBL] [Abstract][Full Text] [Related]
52. Dermatological complications of etanercept therapy for rheumatoid arthritis.
Misery L; Perrot JL; Gentil-Perret A; Pallot-Prades B; Cambazard F; Alexandre C
Br J Dermatol; 2002 Feb; 146(2):334-5. PubMed ID: 11903255
[No Abstract] [Full Text] [Related]
53. Anti-tumor necrosis factor-alpha-induced psoriasis.
Sari I; Akar S; Birlik M; Sis B; Onen F; Akkoc N
J Rheumatol; 2006 Jul; 33(7):1411-4. PubMed ID: 16821276
[TBL] [Abstract][Full Text] [Related]
54. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis.
Goldenberg MM
Clin Ther; 1999 Jan; 21(1):75-87; discussion 1-2. PubMed ID: 10090426
[TBL] [Abstract][Full Text] [Related]
55. Hypersensitivity reaction against influenza vaccine in a patient with rheumatoid arthritis after the initiation of etanercept injections.
Kato T; Kiire A; Yamagata H; Yamanaka H; Kamatani N
Mod Rheumatol; 2006; 16(5):327-9. PubMed ID: 17039318
[TBL] [Abstract][Full Text] [Related]
56. Serious neutropenia following etanercept administration in a 62 years female patient of rheumatoid arthritis.
Datta K; Ghosh RK; Ghosh SM
J Assoc Physicians India; 2010 Oct; 58():643-4. PubMed ID: 21510121
[TBL] [Abstract][Full Text] [Related]
57. Etanercept in arthritis.
Scott DL
Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
[TBL] [Abstract][Full Text] [Related]
58. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
[TBL] [Abstract][Full Text] [Related]
59. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
[TBL] [Abstract][Full Text] [Related]
60. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
